Clinical trial NCT06476756: Combined Effects of Active Cycle Breathing Technique and Buteyko Technique in Post Sternotomy Patients
Official title: Combined Effects of Active Cycle Breathing Technique and Buteyko Technique on Airway Clearance in Post Sternotomy Patients
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Sternotomy
Keywords: Buteyko
Lead sponsor: Riphah International University
Sponsor class: OTHER
First posted: 2024-06-26
Enrollment: 32
Sex: ALL
Minimum age (years): 40
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Group A: combine effects of ACBT and Buteyko techniques will be performed first 3days of cardiac rehab phase 1.

Group B: effect of buteyko techniques will be performed first three days of cardiac rehab phase 1.
Primary purpose: OTHER

Brief summary: This randomized clinical trial seeks to compare the efficacy of the Active Cycle of Breathing Technique (ACBT) and Buteyko breathing techniques in sternotomy patients undergoing coronary artery bypass graft (CABG) surgery, aged 30 to 60. Data will be collected from Surgical Intensive Care Unit (ICU) in selected hospitals. Participants will be assigned to intervention to receiving ACBT and Buteyko breathing techniques standard protocol including chest percussion , tissue blowing exercises, incentive spirometer , cough technique, breathing control, deep breathing, and deep breathing techniques.

Detailed description: This randomized clinical trial seeks to compare the efficacy of the Active Cycle of Breathing Technique (ACBT) and Buteyko breathing techniques in sternotomy patients undergoing coronary artery bypass graft (CABG) surgery, aged 30 to 60. Data will be collected from Surgical Intensive Care Unit (ICU) in selected hospitals. Participants will be assigned to intervention to receiving ACBT and Buteyko breathing techniques standard protocol including chest percussion , tissue blowing exercises, incentive spirometer , cough technique, breathing control, deep breathing, and deep breathing techniques. The three-day trial, starting upon ICU/CCU admission, will measure primary and secondary outcomes before and after each session for both groups. Statistical analysis using SPSS version 25 will be employed post data collection.

Eligibility criteria: Inclusion Criteria:

* Age 40-60 years
* Patient underwent cardiac surgery for first time
* Having speaking, hearing, cognitive ability
* Both genders ( Male and female)
* On mechanical ventilation for less than 24h after surgery

Exclusion Criteria:

* • Hemodynamic ally unstable patients

  * Patients with reopening of sternum
  * Infection patients
  * Renal failure
  * Arrhythmia
  * Patient on mechanical ventilator
  * Cancer
  * Tuberculosis

Primary outcomes:
measure: Borg dyspnea scale
timeFrame: base line and 4 week
measure: BREATHLESSNESS, COUGH AND SPUTUM SCALE (BCSS)
timeFrame: 4 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Lahore
country: Pakistan
facility: Gulab Devi teaching hospital
state: Punjab
Study officials:
affiliation: Riphah International University
name: Sidra Faisal, PP-DPT
role: PRINCIPAL_INVESTIGATOR
References:
citation: Cappello IA, Candelari M, Pannone L, Monaco C, Bori E, Talevi G, Ramak R, La Meir M, Gharaviri A, Chierchia GB, Innocenti B, de Asmundis C. 3D Printed Surgical Guide for Coronary Artery Bypass Graft: Workflow from Computed Tomography to Prototype. Bioengineering (Basel). 2022 Apr 19;9(5):179. doi: 10.3390/bioengineering9050179.
citation: Frak W, Wojtasinska A, Lisinska W, Mlynarska E, Franczyk B, Rysz J. Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease. Biomedicines. 2022 Aug 10;10(8):1938. doi: 10.3390/biomedicines10081938.
citation: Kamiya K, Takei M, Nagai T, Miyoshi T, Ito H, Fukumoto Y, Obara H, Kakuma T, Sakuma I, Daida H, Iimuro S, Shimokawa H, Kimura T, Nagai R, Anzai T. Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study. J Atheroscler Thromb. 2024 Jan 1;31(1):61-80. doi: 10.5551/jat.64304. Epub 2023 Aug 11.